Literature DB >> 8586097

A procedure for wall detection in [18F]FDG positron emission tomography heart studies.

C Landoni1, V Bettinardi, G Lucignani, M C Gilardi, G Striano, F Fazio.   

Abstract

Quantitative positron emission tomography (PET) heart studies require the accurate localization of regions of interest (ROIs) on the myocardial wall (MW) and left ventricle (LV). The procedure is often inaccurate, especially when there is low tracer uptake. We implemented a data processing technique to improve the accuracy of the localization of ROIs on the MW and LV in fluorine-18 labelled deoxyglucose ([18F]FDG) PET heart studies. This technique combines transmission data, acquired before tracer administration and used for attenuation correction, and dynamic emission data (DY), acquired to obtain myocardial time-activity curves and used to calculate regional myocardial glucose utilization, to generate a new set of "transmission" images (TRDY) with enhanced contrast between MW and LV. These new transmission images identify the extravascular myocardial tissue and can be used for ROI placement. Validation of the method was performed in 25 patients, studied after an oral glucose load, by drawing irregular ROIs on three transaxial slices outlining the septum and anterior-apical and lateral wall on the last frame of the DY images (steady state) and then on the TRDY images. Two kinds of analysis were performed on a total of 225 myocardial segments: (1) mean counts per pixel in the DY images from ROIs independently drawn on DY and TRDY images were compared; (2) TRDY ROIs were copied onto DY images and repositioned in the event of mismatch between ROIs and myocardial tissue edge. Mean counts per pixel in the DY images from the original and the repositioned TRDY ROIs were compared. An excellent correlation was found in both cases (using TRDY and DY ROIs: y=0.908 x+0.068, r=0.97; using TRDY ROIs alone: y=0.975 x+0.006, r=0.99). This technique can be used for clinical applications in physiological and pathological conditions in which the myocardial [18F]FDG uptake is reduced or minimal, including diabetes and myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8586097     DOI: 10.1007/bf01736985

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  18 in total

1.  Evaluation of emission-transmission registration in thoracic PET.

Authors:  J N Yu; F H Fahey; B A Harkness; H D Gage; C G Eades; J W Keyes
Journal:  J Nucl Med       Date:  1994-11       Impact factor: 10.057

2.  Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose.

Authors:  N Tamaki; H Ohtani; K Yamashita; Y Magata; Y Yonekura; R Nohara; H Kambara; C Kawai; K Hirata; T Ban
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

3.  Experimental studies on myocardial glucose metabolism of rats with 18F-2-fluoro-2-deoxy-D-glucose.

Authors:  K Yamada; S Endo; H Fukuda; Y Abe; S Yoshioka; M Itoh; K Kubota; J Hatazawa; T Satoh; T Matsuzawa
Journal:  Eur J Nucl Med       Date:  1985

4.  Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia.

Authors:  R C Marshall; J H Tillisch; M E Phelps; S C Huang; R Carson; E Henze; H R Schelbert
Journal:  Circulation       Date:  1983-04       Impact factor: 29.690

5.  "Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity.

Authors:  R L Wahl; L E Quint; R D Cieslak; A M Aisen; R A Koeppe; C R Meyer
Journal:  J Nucl Med       Date:  1993-07       Impact factor: 10.057

6.  Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.

Authors:  G Lucignani; G Paolini; C Landoni; M Zuccari; G Paganelli; L Galli; G Di Credico; G Vanoli; C Rossetti; M A Mariani
Journal:  Eur J Nucl Med       Date:  1992

7.  The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers.

Authors:  J J Berry; J A Baker; K S Pieper; M W Hanson; J M Hoffman; R E Coleman
Journal:  J Nucl Med       Date:  1991-08       Impact factor: 10.057

8.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography.

Authors:  J Tillisch; R Brunken; R Marshall; M Schwaiger; M Mandelkern; M Phelps; H Schelbert
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

9.  Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography.

Authors:  R Brunken; J Tillisch; M Schwaiger; J S Child; R Marshall; M Mandelkern; M E Phelps; H R Schelbert
Journal:  Circulation       Date:  1986-05       Impact factor: 29.690

10.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.

Authors:  K Hamacher; H H Coenen; G Stöcklin
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

View more
  1 in total

1.  P-glycoprotein at the blood-brain barrier: kinetic modeling of 11C-desmethylloperamide in mice using a 18F-FDG μPET scan to determine the input function.

Authors:  Lieselotte Moerman; Dieter De Naeyer; Paul Boon; Filip De Vos
Journal:  EJNMMI Res       Date:  2011-07-29       Impact factor: 3.138

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.